Literature DB >> 16275162

Efficient control of gene expression in the hematopoietic system using a single Tet-on inducible lentiviral vector.

Isabelle Barde1, Maria Antonietta Zanta-Boussif, Sylvain Paisant, Marylene Leboeuf, Philippe Rameau, Christophe Delenda, Olivier Danos.   

Abstract

This work addresses the problem of efficient control of gene expression in the context of viral vectors, which still represents a difficult challenge. A number of lentiviral vectors incorporating the different elements of regulatable transcriptional systems have been described, but they fail to perform satisfactorily either because of a poor dynamic range of transcription levels or because they display high background activities in the uninduced state and mediocre inducer response. We report here on the systematic comparison of vector designs containing the elements of the doxycycline-inducible Tet-on system in their most advanced versions (rtTA2S-M2 transactivator and tTS(Kid) repressor). We show that a simple "all-in-one" vector can be obtained and used for efficient control of transgene expression in long-term tissue culture and in the hematopoietic system of mice following bone marrow transplantation. Using this vector, the uninduced state can be kept at background levels and induction factors of 100-fold are repeatedly obtained over months both in tissue culture and in vivo. Interestingly, the low background activity of the all-in-one vector renders the use of the tTS repressor dispensable, avoiding the problem of progressive loss of inducibility over time associated with irreversible modifications of the chromatin surrounding proviral sequences.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16275162     DOI: 10.1016/j.ymthe.2005.09.012

Source DB:  PubMed          Journal:  Mol Ther        ISSN: 1525-0016            Impact factor:   11.454


  34 in total

1.  Anatomically shaped tissue-engineered cartilage with tunable and inducible anticytokine delivery for biological joint resurfacing.

Authors:  Franklin T Moutos; Katherine A Glass; Sarah A Compton; Alison K Ross; Charles A Gersbach; Farshid Guilak; Bradley T Estes
Journal:  Proc Natl Acad Sci U S A       Date:  2016-07-18       Impact factor: 11.205

2.  Tissue-engineered cartilage with inducible and tunable immunomodulatory properties.

Authors:  Katherine A Glass; Jarrett M Link; Jonathan M Brunger; Franklin T Moutos; Charles A Gersbach; Farshid Guilak
Journal:  Biomaterials       Date:  2014-04-22       Impact factor: 12.479

3.  CRISPR/Cas9 Technology in Restoring Dystrophin Expression in iPSC-Derived Muscle Progenitors.

Authors:  Yue Jin; Yan Shen; Xuan Su; Neal Weintraub; Yaoliang Tang
Journal:  J Vis Exp       Date:  2019-09-14       Impact factor: 1.355

4.  Herpes simplex encephalitis in children with autosomal recessive and dominant TRIF deficiency.

Authors:  Vanessa Sancho-Shimizu; Rebeca Pérez de Diego; Lazaro Lorenzo; Rabih Halwani; Abdullah Alangari; Elisabeth Israelsson; Sylvie Fabrega; Annabelle Cardon; Jerome Maluenda; Megumi Tatematsu; Farhad Mahvelati; Melina Herman; Michael Ciancanelli; Yiqi Guo; Zobaida AlSum; Nouf Alkhamis; Abdulkarim S Al-Makadma; Ata Ghadiri; Soraya Boucherit; Sabine Plancoulaine; Capucine Picard; Flore Rozenberg; Marc Tardieu; Pierre Lebon; Emmanuelle Jouanguy; Nima Rezaei; Tsukasa Seya; Misako Matsumoto; Damien Chaussabel; Anne Puel; Shen-Ying Zhang; Laurent Abel; Saleh Al-Muhsen; Jean-Laurent Casanova
Journal:  J Clin Invest       Date:  2011-11-21       Impact factor: 14.808

5.  β-catenin confers resistance to PI3K and AKT inhibitors and subverts FOXO3a to promote metastasis in colon cancer.

Authors:  Stephan P Tenbaum; Paloma Ordóñez-Morán; Isabel Puig; Irene Chicote; Oriol Arqués; Stefania Landolfi; Yolanda Fernández; José Raúl Herance; Juan D Gispert; Leire Mendizabal; Susana Aguilar; Santiago Ramón y Cajal; Simó Schwartz; Ana Vivancos; Eloy Espín; Santiago Rojas; José Baselga; Josep Tabernero; Alberto Muñoz; Héctor G Palmer
Journal:  Nat Med       Date:  2012-06       Impact factor: 53.440

6.  Tightly regulated 'all-in-one' lentiviral vectors for protection of human hematopoietic cells from anticancer chemotherapy.

Authors:  N Lachmann; S Brennig; R Hillje; H Schermeier; R Phaltane; J Dahlmann; I Gruh; N Heinz; B Schiedlmeier; C Baum; T Moritz
Journal:  Gene Ther       Date:  2015-06-30       Impact factor: 5.250

7.  Scaffold-mediated lentiviral transduction for functional tissue engineering of cartilage.

Authors:  Jonathan M Brunger; Nguyen P T Huynh; Caitlin M Guenther; Pablo Perez-Pinera; Franklin T Moutos; Johannah Sanchez-Adams; Charles A Gersbach; Farshid Guilak
Journal:  Proc Natl Acad Sci U S A       Date:  2014-02-18       Impact factor: 11.205

Review 8.  Turning the gene tap off; implications of regulating gene expression for cancer therapeutics.

Authors:  James F Curtin; Marianela Candolfi; Weidong Xiong; Pedro R Lowenstein; Maria G Castro
Journal:  Mol Cancer Ther       Date:  2008-03       Impact factor: 6.261

Review 9.  Vector design for expression of O6-methylguanine-DNA methyltransferase in hematopoietic cells.

Authors:  Axel Schambach; Christopher Baum
Journal:  DNA Repair (Amst)       Date:  2007-05-07

10.  Bone marrow stem cells expressing keratinocyte growth factor via an inducible lentivirus protects against bleomycin-induced pulmonary fibrosis.

Authors:  Susana Aguilar; Chris J Scotton; Katrina McNulty; Emma Nye; Gordon Stamp; Geoff Laurent; Dominique Bonnet; Sam M Janes
Journal:  PLoS One       Date:  2009-11-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.